phase readout
saveNCT04577404: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Tanabe Pharma America, Inc.. Phase: PHASE3. Conditions: Amyotrophic Lateral Sclerosis (ALS)
view source ↗
comments(0)
5-min edit window · permanent after that